Create your personal profile and easily find a job you love.
Sign up
Adaptimmune
Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer.
Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these...
Adaptimmune
Adaptimmune, a leader in T-cell therapy, is a multinational, clinical-stage biopharmaceutical company focused on developing novel immunotherapies using its proprietary SPEAR T-cell receptor platform to treat solid tumors, which has the potential to transform the treatment of cancer.
Our proprietary SPEAR T-cell platform has generated a strong pipeline of affinity-enhanced T-cell therapies, with multiple INDs open. We use these...
Opportunities
Interesting to know
This company page was generated automatically and therefore features only limited information. Find out more about Adaptimmune on their company website:
Interested in working at Adaptimmune?
When you connect, your chance of being approached for an opportunity at this company is 3 times higher.
People also viewed
View what's on offer:
Change language to: Dutch
This page is optimised for people from the UK. View the version optimised for people from the Netherlands.